TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pharmbiotech Oy
Closing information (x1000 EUR)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
2,000
|
47
|
0 |
Financial expenses |
15
|
0 | |
Earnings before taxes |
564
|
188
|
-5 |
Total assets |
761
|
2,609
|
2,413 |
Current assets |
368
|
393
|
1,993 |
Current liabilities |
2
|
2,026
|
2,004 |
Equity capital |
8
|
17
|
9 |
- share capital |
3
![]() |
3
![]() |
3 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
1.1%
|
0.7%
|
0.4% |
Turnover per employee | |||
Profit as a percentage of turnover |
28.2%
|
400% | |
Return on assets (ROA) |
7.8%
|
-0.2% | |
Current ratio |
18400%
|
19.4%
|
99.5% |
Return on equity (ROE) |
7050.0%
|
1105.9%
|
-55.6% |
Change turnover |
1,953
|
47 | |
Change turnover % | 4155% | ||
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.